Work

CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma

Year: 2019

Type: article

Source: Gut

DOI: 10.1136/gutjnl-2019-318506

Authors: Cun Wang, Hui Wang, Cor Lieftink, Aimee du Chatinier, Dongmei Gao, Guangzhi Jin, Haojie Jin, Roderick L Beijersbergen, Wenxin Qin, René Bernards

Institutions: Shanghai Jiao Tong University, Renji Hospital, The Netherlands Cancer Institute, Shanghai Cancer Institute, Oncode Institute, State Key Laboratory of Oncogene and Related Genes, Fudan University, Zhongshan Hospital, Second Military Medical University, Eastern Hepatobiliary Surgery Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, KWF Kankerbestrijding

Awards: G209324194, G3378960174, G5353037363, G6291131255, G7151166268

OpenAlex ID: W2972522329

FWCI: 9.003

Cites: 37

Cited by: 107

Related to: 10